Objective:

To investigate the role of metformin in reducing posterior capsule opacification (PCO) after cataract surgery.

Approach:

Key Findings:

• Metformin was detectable in all excised lens capsule specimens, with capsule and serum concentrations significantly correlated.
• Capsule concentrations did not differ significantly between low-dose and high-dose groups.
• Metformin treatment significantly attenuated LEC proliferation in vitro compared to controls.

Interpretation:

The findings suggest that metformin may play a protective role against PCO by suppressing LEC proliferation, potentially explaining conflicting epidemiological data regarding diabetes and PCO risk.

Limitations:

• The study involved a small sample size of 20 patients.
• Variability in serum levels of metformin may affect generalizability.

Conclusion:

The study provides evidence that metformin accumulates in the human lens capsule and suppresses LEC proliferation, warranting larger studies to further explore its potential as a pharmacological adjunct in PCO prevention.

Sources:

• British Journal of Ophthalmology
Source

Based on findings from:

Metformin’s Potential Role in Posterior Capsule Opacification

The Ophthalmologist, 2026.

https://www.theophthalmologist.com/issues/2026/articles/march/metformins-potential-role-in-posterior-capsule-opacification/

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.